Macula Risk®
Macula Risk is a test that determines your risk of losing your vision from AMD. It uses a simple cheek swab to detect the presence of certain genetic markers that are known to be responsible for vision loss. These genetic markers can then be analyzed to determine exactly how high your risk is of losing your sight.
Why is risk detection so important?:
Early detection, diagnosis and treatment can lead to better visual outcomes. When you understand your risk, you and your eye care provider can develop a personalized program to manage your disease. Monitoring and treatment can begin before your symptoms progress, enabling you to slow down or prevent the progression of the disease.
AMD cannot be reversed, however vision loss associated with it can be prevented or delayed through early detection, diagnosis and treatment. The earlier you understand your risk level, the better your chances are to save your sight.
Macula Risk® Laboratory:
Macula Risk
® tests are performed at Bay Area Genetic Laboratory in Canada or at Kimball Genetics in the United States. These laboratories are high complexity genetic testing laboratories operating under CLIA and CAP regulatory oversight.
Bay Area Genetic Laboratory
Suite 205B, Sir William Osler Health Institute
565 Sanatorium Road
Hamilton, ON, Canada
L9C 7N4
Kimball Genetics Inc.
Suite 225
650 Cherry Street
Denver, CO, USA
80246
Macula Risk® may be covered by Extended Benefit Plans, Healthcare Spending Accounts, or Flex Plans.
Ask your insurance provider about your coverage.